Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ling Chi Medicine Company (Hong Kong) Limited (also known as Ling Chi Medicine Company or 香港靈芝藥廠有限公司) is a legacy pharmaceutical company based in Hong Kong, founded in 1968. The company is historically renowned for manufacturing and distributing traditional Chinese medicines and over-the-counter (OTC) remedies, most notably Shiling Oil (十靈油), Saplingtan (十靈丹), and Col-gan (傷風克). In January 2017, Jacobson Pharma Corporation Limited acquired the key assets, trademarks, and product portfolios of Ling Chi Medicine Company for its branded healthcare business. These acquired brands were subsequently integrated into JBM Healthcare Limited, a spin-off of Jacobson Pharma. Despite the asset sale, the corporate entity of Ling Chi Medicine Company remains registered and active in Hong Kong.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ling Chi Medicine Company.